We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Expeditors International
EXPD
$22.9B
| $22.8M | 0.1% |
+180,156
| New | +$21.3M |
|
202
General Mills
GIS
$19.2B
| $22.7M | 0.1% |
372,154
+240,304
| +182% | +$14.9M |
|
203
Cleveland-Cliffs
CLF
$6.81B
| $22.6M | 0.1% |
1,048,792
+651,920
| +164% | +$12.8M |
|
204
Workday
WDAY
$33.4B
| $22.6M | 0.1% |
94,539
+79,378
| +524% | +$19.1M |
|
|
HERA
205
DELISTED
FTAC Hera Acquisition Corp. Class A Ordinary Shares
HERA
| $22.5M | 0.1% |
+2,303,976
| New | +$22.5M |
|
206
Citigroup
C
$222B
| $22.3M | 0.1% |
314,866
+312,881
| +15,762% | +$23.1M |
|
207
CALL
iShares MSCI EAFE ETF
EFA
$76.4B
| $22.2M | 0.1% |
281,700
+268,600
| +2,050% | +$21.3M |
|
|
PRAH
208
DELISTED
PRA Health Sciences, Inc.
PRAH
| $22.2M | 0.1% |
134,119
-2,979
| -2% | -$497K |
|
|
CTLT
209
DELISTED
CATALENT, INC.
CTLT
| $22.1M | 0.1% |
204,142
+190,811
| +1,431% | +$20.4M |
|
210
Expedia Group
EXPE
$31.2B
| $21.8M | 0.1% |
133,409
-371,280
| -74% | -$63.7M |
|
211
Deere & Co
DE
$170B
| $21.8M | 0.1% |
61,909
+15,618
| +34% | +$5.7M |
|
212
Fox Class B
FOX
$20.7B
| $21.7M | 0.1% |
617,523
+274,329
| +80% | +$9.93M |
|
213
Eli Lilly
LLY
$1.07T
| $21.6M | 0.1% |
94,314
+74,151
| +368% | +$14.9M |
|
214
Canadian Imperial Bank of Commerce
CM
$107B
| $21.6M | 0.1% |
378,934
-95,050
| -20% | -$5.21M |
|
215
Idexx Laboratories
IDXX
$42.9B
| $21.6M | 0.1% |
34,178
+12,985
| +61% | +$7.17M |
|
216
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$13B
| $21.5M | 0.1% |
275,500
+140,000
| +103% | +$10.1M |
|
217
Yum China
YUMC
$14.9B
| $21.4M | 0.1% |
323,029
-358,483
| -53% | -$22.9M |
|
|
GRMN
218
Garmin
GRMN
$46.9B
| $21.4M | 0.1% |
147,892
-38,775
| -21% | -$5.44M |
|
219
iShares MSCI Germany ETF
EWG
$1.5B
| $21.4M | 0.1% |
617,702
+445,222
| +258% | +$15.6M |
|
|
PLAN
220
DELISTED
Anaplan, Inc.
PLAN
| $21.3M | 0.1% |
399,395
+351,016
| +726% | +$19.5M |
|
|
MNDT
221
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $21.1M | 0.1% |
1,043,793
+300,788
| +40% | +$6.17M |
|
222
Cooper Companies
COO
$13.7B
| $21M | 0.1% |
212,120
+116,832
| +123% | +$11.4M |
|
223
PUT
Alphabet (Google) Class A
GOOGL
$3.91T
| $20.8M | 0.09% |
170,000
+114,000
| +204% | +$13.3M |
|
224
Las Vegas Sands
LVS
$30.5B
| $20.7M | 0.09% |
393,715
-148,846
| -27% | -$8.59M |
|
225
Arrowhead Research
ARWR
$12.1B
| $20.7M | 0.09% |
+250,380
| New | +$18.6M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.